– Study will assess the safety, pharmacokinetic and pharmacodynamic profiles and anti-tumor activity for CV6-168 in the treatment of multiple solid cancers, including colon, gastric, breast, ovarian, ...

BELFAST, United Kingdom, Dec. 14, 2023 (GLOBE NEWSWIRE) -- CV6 Therapeutics (‘CV6’), a drug development biotechnology company that specializes in innovative small molecule therapeutics for cancer and ...

Belfast, UK, 2 November 2022 – CV6 Therapeutics (‘CV6’), a drug development biotechnology company that specializes in innovative small molecule therapeutics for cancer and inflammatory diseases, ...

A QUEEN'S University spin-in which has developed a potentially life-saving new cancer treatment is to invest £8 million to take its first anti-cancer drug through a first-in-human clinical trial. CV6 ...

CV6 Therapeutics (NI) Ltd. has secured US$9.2 million to progress its lead oncology asset CV6-168 into a first-in-human phase Ia trial and perform further scientific development work. CV6-168 is a ...

LiteOn (the company behind Plextor) released a new line of SATA 6.0 Gbps SSDs, the CV6. It is available in three storage capacities: 128GB, 256GB and 512GB. he 2.5-inch SSDs (7mm thick) is made with ...

CV6 Therapeutics is developing next-generation cancer treatment, and it is looking backwards to make the future better. Emily McDaid reports. CV6 Therapeutics doesn’t replace traditional chemotherapy; ...

CV6 Therapeutics will conduct further research with Queen’s University Belfast while clinical trials are going on. Belfast-based CV6 Therapeutics has raised £8m to invest in clinical trials and ...

Belfast-based drug development company CV6 Therapeutics said it will invest almost £8 million (€9.3 million) in clinical trials and further development work on its first anti-cancer drug. The funding ...

CV6 Therapeutics Ltd. raised $9.2 million in grant and equity funding to move a first-in-class inhibitor of deoxyuridine 5’-triphosphate nucleotidohydrolase (dUTPase) into a phase Ia trial in cancer.

LiteOn is yet to announce price and availability for the CV6 SSD range. More information as we get it.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. A pill developed in Northern Ireland with the potential to treat the most common and deadly cancers will begin ...